Pyrrolizidine poisoning: A neglected area in human toxicology

Therapeutic Drug Monitoring

Volumn 23, Issue 6, 2001, Pages 698-708

  Stewart, M J ^a   Steenkamp, V ^a  

^a UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

Herbal medicine; Human poisoning; Pyrrolizidine alkaloids

Indexed keywords

PLANT TOXIN; PYRROLIZIDINE;

ARTICLE; CLINICAL FEATURE; FOOD CONTAMINATION; HERBAL MEDICINE; HUMAN; INTOXICATION; METABOLISM; PRIORITY JOURNAL; TOXICITY TESTING;

HUMANS; PYRROLIZIDINE ALKALOIDS;

EID: 0035178817     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200112000-00018     Document Type: Article

References (176)

1. Herbal teas and toxins: Novel aspects of pyrrolizidine poisoning in the United States
2. Senecio: A dangerous plant for man and beast
3. The senecio alkaloids
4. The vomiting sickness of Jamaica: A review
5. The toxic effects of crotalaria extract on the livers of rats
6. Herbal teas and toxins: Novel aspects of pyrrolizidine poisoning in the United states
7. An experimental study of Senecio poisoning in rats
8. Senecio disease or cirrhosis of the liver due to Senecio poisoning
9. Veno-occlusive disease of the liver-some new aspects
10. Planttoksiene en lewersiektes by kinders in Pretoria en omgewing
11. Clinical and analytical aspects of pyrrolizidine poisoning caused by South African traditional medicines
12. Veno-occlusive disease of the liver
13. Cirrhosis of the liver in Jamaica
14. Pathological anatomy of atrophic hepatic cirrhosis
15. Hepatosplenomegaly against the background of heliotropic toxicosis
16. The chronic pathological effects on the liver of the rat of the pyrrolizidine alkaloids heliotrine, lasiocarpine nd their N-oxides
17. An outbreak of hepatic veno-occlusive disease in North-Western Afghanistan
18. Heliotrope poisoning in Tadjikistan
19. Hepatic veno-occlusive disease originating in Ecuador
20. Hepatic veno-occlusive disease due to pyrrolizidine (Senecio) poisoning in Arizona
21. Pyrrolizidine (Senecio) intoxication mimicking Reyes syndrome
22. Hepatic venoocclusive disease associated with the consumption of pyrrolizidine-containing dietary supplements
23. Veno-occlusive disease of the liver secondary to the ingestion of Comfrey
24. Comfrey herb tea-induced hepatic veno-occlusive disease
25. Hepatic vein occlusion disease in Egyptian children
26. Hepatic veno-occlusive disease due to toxic alkaloids in herbal tea
27. Toxicity and carcinogenic action of pyrrolizidine alkaloids
28. Health risks of herbal remedies
29. Comfrey herb tea and hepatic venoocclusive disease
30. Hepatic veno-occlusive disease in a newborn infant of a woman drinking herbal tea
31. Reversible hepatic venoocclusive disease in an infant after consumption of pyrrolizidinecontaining herbal tea
32. Pyrrolizidine (Senecio) intoxication mimicking Reyes syndrome
33. Senecio poisoning exhibiting as Chiari's syndrome: A report of twelve cases
34. An epidemic of venoocclusive disease of the liver in Afghanistan. Pathologic features
35. The etiology of toxic hepatitis with ascites
36. Herbal tea induced hepatic venoocclusive disease: Quantification of toxic alkaloid exposure in adults
37. Herbal medicine s and veno-occlusive disease in India
38. Veno-occlusive disease of the liver with non-portal type of cirrhosis ocurring in Jamaica
39. Veno-occlusive disease in children in Barbados asssociated with the drinking of herb teas made from Crotalaria plants
40. An epidemic of veno-occlusive disease of the liver in central India
41. Milk transfer of pyrrolizidine alkoloids in cattle
42. Pyrrolizidine alkaloids: Their appearance in honey from tansy ragwort (Senecio Jacobea L.)
43. Pyrrolizidine alkaloids in honey from Echium plantagineum L
44. Health hazards of unusual herbal teas
45. Toxicity of comfrey-pepsin preparatiuons
46. Hepatic venocclusive disease associated with the consumption of pyrrolizidinecontaining dietary supplements
47. Determination of pyrrolizidine alkaloids in Senecio inadequens by capillary gas chromatography
48. Chemistry of toxic range plants: Variation in pyrrolizidine alkaloid content of Senecio, Amsinckia and Crotalaria species
49. Estimated intakes of pyrrolizidine alkaloids by humans. A comparison with the dose rates causing tumours in rats
50. Comfrey: Assessing the low dose health risk
51. Pyrrolizidine alkaloid plants, metabolism and toxicity
52. The Pyrrolizidine alkaloids
53. The alkaloids of Senecio latifolius
54. The alkaloids of Crotalaria juncea
55. Structural influences on pyrrolizidine alkaloid-induced cytopathology
56. The Budd-Chiari syndrome and hepatic veno-occlusive disease. Recognition and treatment
57. Plant poisoning in stock and the development of tolerance
58. The Senecio alkaloids. Part VI. The isomerisation of senecic acid to trans-senecic (integerrinecic) acid, and the general structure of the 'necic' acids
59. The identity of Blongilobine ewith retrorsine
60. The toxic actions of pyrrolizidine (Senecio) alkaloids
61. Toxicity of pyrrolizidine alkaloids from Riddell groundsel (Senecio riddellii) to cattle
62. Toxic principles of senecio-species
63. Kwashiorkor like syndrome and other pathological changes in rats as a result of feeding with Senecio alkaloids (Isatidine)
64. Pyridine nucleotide cofactor requirements of indicine N-oxide reduction by hepatic microsomal cytochrome P-450
65. Bioactivation and detoxication of the pyrrolizidine alkaloid senecionine by cytochrome P-450 enzymes in rat liver
66. Role of cytochrome P450IIIA4 in the metabolism of the pyrrolizidine alkaloid senecionine in human liver
67. Toxicity and metabolism of pyrrolizidine alkaloids
68. Potential metabolic bioactivation pathways involving cyclic tertiary amines and azaarenes
69. Cardiopulmonary actions of monocrotic and monocrotalic acids: Hydrolysis products of the pyrrolizidine alkaloid, monocrotaline
70. Detection of sulphur-conjugated pyrrolic metabolites in blood and fresh or fixed liver tissue from rats given a variety of toxic pyrrolizidine alkaloids
71. Recent chromatographic methods to isolate pyrrolizidine alkaloids
72. N-acetyl cysteine conjugated pyrrole identified in rat urine following administration of two pyrrolizidine alkaloids, monocrotaline and senecionine
73. Detection of a reactive pyrrole in the hepatic metabolism of the pyrrolizidine alkaloid, monocrotaline
74. Quantitation of the hepatic release of metabolites of the pyrrolizidine alkaloid, monocrotaline
75. The effect of a pyrrolizidine alkaloid, monocrotaline, on the biochemical functions of the pulmonary endothelium
76. Identity of a biliary metabolite formed from monocrotaline in isolated, perfused rat liver
77. Alkylation of N2 in deoxyguanosine by dehydroretronecine, a carcinogenic metabolite of the pyrrolizidine alkaloid monocrotaline
78. Characterisation of hepatic DNA damage induced in rats by the pyrrolizidine alkaloid, monocrotaline
79. Hepatic veins of monkeys with veno occlusive disease: Sequential ultrastructural changes
80. The relationship between the concentration of the pyrrolizidine alkaloid monocrotaline and the pattern of metabolites released from the isolated liver
81. Excretion of the pyrrolizidine alkaloid heliotrine in the urine and bile of sheep
82. The relationship between the concentration of the pyrrolizidine alkaloid monocrotaline and the pattern of metabolites released from the isolated liver
83. Relationship between glutathione concentration and metabolism of the pyrrolizidine alkaloid, monocrotaline, in the isolated, perfused liver
84. Microsomal formation of a pyrrolic alcohol glutathione conjugate of clivorine. Firm evidence for the formation of a pyrrolic metabolite of an otonecine-type pyrrolizidine alkaloid
85. Toxicity of pyrrolizidine alkaloids
86. Excretion and alteration of monocrotaline in rats
87. Metabolism of toxic pyrrolizidine alkaloids from tansy ragwort (Senecio jacobaea) in ovine ruminal fluid under anaerobic conditions
88. Liver disease in Jamaican Children (serious hepatosis)
89. Autonomous phlebitis obliterans of the main stem of the hepatic vein as a cause of death
90. Hepatic veno-occlusive disease in the newborn infant of a woman drinking herbal tea
91. Senecio poisoning exhibiting as Chiari's syndrome
92. Senecio species: Toxic plants used as food and medicine in Transkei
93. Further observations on subacute and chronic liver changes in rats after a single dose of various pyrrolizidine (Senecio) alkaloids
94. Crotalaria spectabilis cirrhosis in turkeys
95. Pyrrolizidine alkaloid poisoning in rats
96. Effect of age on the development of cor pulmonale in non-human primates following pyrrolizidine alkaloid intoxication
97. Monocrotaline model of non cardiogenic pulmonary edema in dogs
98. The relationship between reactivity of metabolites of pyrrolizidine alkaloids and extrahepatic toxicity
99. Physicochemical and metabolic basis for the differing neurotoxicity of the pyrrolizidine alkaloids, trichodesmine and monocrotaline
100. Role of metabolism in monocrotaline-induced immunotoxicity in C57BL/6 mice
101. An investigation of the hepatotoxic effects in the fowl of Ragwort, with special reference to the induction of liver tumours with seneciphylline
102. Effects of whole-body irradiation, and of partial hepatectomy, on the liver lesions induced in rats by a single dose of retrorsine, a pyrrolizidine (Senecio) alkaloid
103. Dehydroretronecine-induced rhabdomyosarcomas in rats
104. Carcinogenic activity of clivorine. A pyrrolizidine alkaloid isolated from Ligularia dentata
105. Neoplastic transformation in tissues of rats exposed to monocrotaline or dehydroretronecine
106. Malignant tumors in rats given lasiocarpine
107. Carcinogens are mutagens: A simple test combining liver homogenates for activation and bacteria for detection
108. Naturally occuring mutagens
109. Malformations in foetal rats induced by the pyrrolizidine alkaloid heliotrine
110. Carcinogenic activity of Symphitum officinale
111. DNA cross-linking in mammalian cells by pyrrolizidine alkaloids
112. Structural influences on pyrrolizidine alkaloid-induced cytopathology
113. Chromosomal breakage by pyrrolizidine alkaloids and modification of the effect by Cysteine
114. Preliminary findings of chromosome studies in rats and humans with veno-occlusive disease
115. The effects of Senecio alkaloid (monocrotaline) on human embryo liver in tissue culture
116. The effects of lasiocarpine, retrorsine and retronecine pyrrole on human embryo lung and liver cells in culture
117. The effect of heliotrine, a pyrrolizidine alkaloid on human liver cells in culture
118. Evaluation of the single cell gel electrophoresis assay with human hepatoma (Hep G2) cells
119. Localization in the cell cycle of the antimitotic action of the pyrrolizidine alkaloid, lasiocarpine and its metabolite, dehydroheliotridine
120. Clinical course of heliotrope hepatomegaly
121. Pyrrolizidine alkaloids in human diet
122. Synergistic hepatotoxicity from coexposure to bacterial endotoxin and the pyrrolizidine alkaloid monocrotaline
123. Induction of cytochrome P450 enzymes in the livers of rats treated with the pyrrolizidine alkaloid retrorsine
124. Natural plant toxicants in milk: A review
125. Capillary gas chromatographyfourier transform infrared spectroscopy of pyrrolizidine alkaloids of Senecio inaequidens DC
126. GC/MS/MS detection of pyrrolic metabolites in animals poisoned with the pyrrolizidine alkaloid riddelliine
127. Pyrrolizidine alkaloids from Symphytum officinale L, and their percutaneous absorption in rats
128. Preparative isolation of pyrrolizidine alkaloids derived from Senecio vulgaris
129. Comparative analysis of pyrrolizidine alkaloids from natural sources by gas chromatography-mass spectrometry
130. A sensitive method for the detection and quantitative determination of pyrrolizidine alkaloids
131. Spectrophotometric determination of pyrrolizidine alkaloids-some improvements
132. Hepatic veno-occlusive disease due to a traditional remedy: Confirmation of toxic pyrrolizidine alkaloids as the cause, using simple chemical and in vitro techniques
133. Thin layer chromatography of pyrrolizidine alkaloids
134. Distribution and taxonomic significance of major alkaloids in the genus Podalyria
135. Detection of pyrrolizidine alkaloids on thin layer chromatograms
136. Specific detection of pyrrolizidine alkaloids on thin layer chromatograms
137. The development of a broadspectrum Toxicology screening program in Taiwan
138. Characterisation of pyrrolizidine alkaloids by gas, thin layer and paper chromatography
139. Rapid screening of natural products by high-resolution high-temperature gas chromatography
140. GC-MS determination of pyrrolizidine alkaloids in four senecio species
141. A sensitive anbalytical method for pyrrolizidine alkaloids
142. Gas chromatographic determination of pyrrolizidine alkaloids in goats milk
143. Determination of pyrrolizidine alkaloid metabolites from mouse liver microsomes using tandem mass spectrometry and gas chromatography/mass spectrometry
144. Rapid multi-residue screen for alkaloids in plant material and biological samples
145. Rapid isolation and identification of pyrollizidine alkaloids (senecio vulgaris) by use of high performance liquid chromatography
146. Rapid high-performance liquid chromatography isolation of monoesters, diesters and macrocyclic diester pyrrolizidine alkaloids from Senecio jacobaea and Amsinckia intermedia
147. High-performance liquid chromatographic analysis of pyrrolizidine (Senecio) alkaloids using a reverse-phase styrene-divinylbenzene resin column
148. Method for determination of pyrrolizidine alkaloids and their metabolites by high-performance liquid chromatography
149. Determination of pyrrolizidine alkaloids in honey from selected sites by solid phase extraction and HPLC-MS
150. On-line identification of phytochemical constituents in botanical extracts by combined high-performance liquid chromatographic-diode array detection mass spectrometric techniques
151. Determination of hepatotoxic pyrrolizidine alkaloids by on-line high performance liquid chromatography mass spectrometry with an electrospray interface
152. Poisoning by plant material: Review of human cases and analytical determination of main toxins by highperformance liquid chromatography-(tandem) mass spectrometry
153. Enzyme-linked immunosorbent assay detection of pyrrolizidine alkaloids: Immunogens based on quaternary pyrrolizidinium salts
154. A competitive enzyme immunoassay for the pyrrolizidine alkaloids of the senecionine type
155. A competitive enzyme linked immunosorbent assay (ELISA) to detect retronecine and monocrotaline in vitro
156. A pyrrolizidine alkaloid enzyme Ikinked immunosorbent assay detection strategy
157. Analysis of pyrrolizidine alkaloids: A competitive enzyme-linked immunoassay (ELISA) for the quantitative determination of some toxic pyrrolizidine alkaloids
158. Genneration and characterisation of monoclonal antibodies against he pyrrolizidine alkaloid, retrorsine
159. Chemistry of toxic range plants. Determination of pyrrolizidine alkaloid content and composition in Senecio species by nuclear magnetic resonance spectroscopy
160. Comparison of capillary gas chromatography with IH and 13C nuclear magnetic resonance spectroscopy for the quantitation of pyrrolizidine alkaloids from Senecio vernalis
161. IH and 13C NMR spectral analysis of some necines of toxic pyrrolizidine alkaloids
162. Reversible hepatic venoocclusive disease in an infant after consumption of pyrrolizidinecontaining herbal tea
163. Picroliv protects against monocrotaline-induced hepatic damage in rats
164. Effects of steroidal and non-steroidal microsomal enzyme inducers on the hepatotoxicity of pyrrolizidine alkaloids in rats